A Novel In Vivo Method Using <i>Caenorhabditis elegans</i> to Evaluate α-Glucosidase Inhibition by Natural Products for Type 2 Diabetes Treatment
Background: Non-insulin-dependent diabetes mellitus, or type 2 diabetes, is one of the diseases of greatest concern worldwide, and research into natural compounds that are capable of regulating glycemia and insulin resistance is therefore gaining importance. In the preclinical stages, <i>Caeno...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/12/1685 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|